Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by CELL THERAPEUTICS
Lobbying Relationship
Bills mentioned
S.3187: Food and Drug Administration Safety and Innovation Act
Sponsor: Tom Harkin (D-Iowa)
H.R.4132: FAST Act
Sponsor: Cliff Stearns (R-Fla.)
S.2113: TREAT Act
Sponsor: Kay Hagan (D-N.C.)
H.R.3590: Patient Protection and Affordable Care Act
Sponsor: Charles B. Rangel (D-N.Y.)
S.1796: America's Healthy Future Act of 2009
Sponsor: Max Baucus (D-Mont.)
H.R.6331: Medicare Improvements for Patients and Providers Act of 2008
Sponsor: Charles B. Rangel (D-N.Y.)
S.3101: Medicare Improvements for Patients and Providers Act of 2008
Sponsor: Max Baucus (D-Mont.)
S.3118: Preserving Access to Medicare Act of 2008
Sponsor: Charles E. Grassley (R-Iowa)
H.R.2900: Food and Drug Administration Amendments Act of 2007
Sponsor: John D. Dingell (D-Mich.)
S.1082: Food and Drug Administration Revitalization Act
Sponsor: Edward M. Kennedy (D-Mass.)
H.R.1956: Patient Protection and Innovative Biologic Medicines Act of 2007
Sponsor: Jay Inslee (D-Wash.)
H.R.1038: Access to Life-Saving Medicine Act
Sponsor: Henry A. Waxman (D-Calif.)
S.623: Access to Life-Saving Medicine Act
Sponsor: Charles E. Schumer (D-N.Y.)
S.1695: Biologics Price Competition and Innovation Act of 2007
Sponsor: Edward M. Kennedy (D-Mass.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Judson Greif | n/a |
| Sandy Mathiesen | n/a |
| Will Stone | n/a |
| William Stone | n/a |
| Denny Miller | n/a |
| Sandy Mathieson | n/a |
| Wally Burnett | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate